Raafat, M.; Kamel, A.A.; Shehata, A.H.; Ahmed, A.-S.F.; Bayoumi, A.M.A.; Moussa, R.A.; Abourehab, M.A.S.; El-Daly, M.
Aescin Protects against Experimental Benign Prostatic Hyperplasia and Preserves Prostate Histomorphology in Rats via Suppression of Inflammatory Cytokines and COX-2. Pharmaceuticals 2022, 15, 130.
https://doi.org/10.3390/ph15020130
AMA Style
Raafat M, Kamel AA, Shehata AH, Ahmed A-SF, Bayoumi AMA, Moussa RA, Abourehab MAS, El-Daly M.
Aescin Protects against Experimental Benign Prostatic Hyperplasia and Preserves Prostate Histomorphology in Rats via Suppression of Inflammatory Cytokines and COX-2. Pharmaceuticals. 2022; 15(2):130.
https://doi.org/10.3390/ph15020130
Chicago/Turabian Style
Raafat, Mohamed, Amr A. Kamel, Alaa H. Shehata, Al-Shaimaa F. Ahmed, Asmaa M. A. Bayoumi, Rabab A. Moussa, Mohammed A. S. Abourehab, and Mahmoud El-Daly.
2022. "Aescin Protects against Experimental Benign Prostatic Hyperplasia and Preserves Prostate Histomorphology in Rats via Suppression of Inflammatory Cytokines and COX-2" Pharmaceuticals 15, no. 2: 130.
https://doi.org/10.3390/ph15020130
APA Style
Raafat, M., Kamel, A. A., Shehata, A. H., Ahmed, A. -S. F., Bayoumi, A. M. A., Moussa, R. A., Abourehab, M. A. S., & El-Daly, M.
(2022). Aescin Protects against Experimental Benign Prostatic Hyperplasia and Preserves Prostate Histomorphology in Rats via Suppression of Inflammatory Cytokines and COX-2. Pharmaceuticals, 15(2), 130.
https://doi.org/10.3390/ph15020130